ABVC Projected Dividend Yield
ABVC BioPharma Inc ( NASDAQ : ABVC )ABVC BioPharma is a clinical stage biopharmaceutical company. Co.'s wholly owned subsidiaries, American BriVision Corporation, focuses on the development of ABV-1701 Vitreous Substitute for Vitrectomy. Through its another wholly owned subsidiary, BioLite Holding Inc., Co. conducts clinical research and trials of various drug candidates, including: ABV-1504 for the treatment of Major Depressive Disorder, ABV-1505 to treat Attention-Deficit Hyperactivity Disease, ABV-1501 for the treatment of Triple Negative Breast Cancer, ABV-1703 for the treatment of Pancreatic Cancer, ABV-1702 to treat Myelodysplastic syndromes and ABV-1601 Depression in Cancer Patients. 20 YEAR PERFORMANCE RESULTS |
ABVC Dividend History Detail ABVC Dividend News ABVC Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |